Predictive Oncology Inc. (NASDAQ:POAI) Sees Large Drop in Short Interest

Predictive Oncology Inc. (NASDAQ:POAI) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 395,800 shares, a drop of 22.7% from the February 28th total of 512,300 shares. Based on an average daily trading volume, of 4,350,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 5.6% of the shares of the stock are short sold.

Predictive Oncology Trading Down 0.7 %

NASDAQ:POAI traded down $0.01 during mid-day trading on Wednesday, reaching $1.47. 251,606 shares of the stock were exchanged, compared to its average volume of 2,322,184. The business has a fifty day moving average price of $1.38 and a 200 day moving average price of $1.03. Predictive Oncology has a 1-year low of $0.55 and a 1-year high of $3.06. The firm has a market capitalization of $10.06 million, a PE ratio of -0.48 and a beta of 1.22.

About Predictive Oncology

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.